Northern Trust’s ADMA Biologics ADMA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $44.5M | Sell |
2,443,301
-151,455
| -6% | -$2.76M | 0.01% | 1171 |
|
2025
Q1 | $51.5M | Buy |
2,594,756
+19,681
| +0.8% | +$390K | 0.01% | 1065 |
|
2024
Q4 | $44.2M | Buy |
2,575,075
+145,387
| +6% | +$2.49M | 0.01% | 1201 |
|
2024
Q3 | $48.6M | Buy |
2,429,688
+355,919
| +17% | +$7.11M | 0.01% | 1045 |
|
2024
Q2 | $23.2M | Sell |
2,073,769
-38,894
| -2% | -$435K | ﹤0.01% | 1464 |
|
2024
Q1 | $13.9M | Sell |
2,112,663
-85,371
| -4% | -$563K | ﹤0.01% | 1841 |
|
2023
Q4 | $9.94M | Buy |
2,198,034
+16,081
| +0.7% | +$72.7K | ﹤0.01% | 2077 |
|
2023
Q3 | $7.81M | Buy |
2,181,953
+17,605
| +0.8% | +$63K | ﹤0.01% | 2162 |
|
2023
Q2 | $7.99M | Buy |
2,164,348
+318,183
| +17% | +$1.17M | ﹤0.01% | 2222 |
|
2023
Q1 | $6.11M | Buy |
1,846,165
+191,435
| +12% | +$634K | ﹤0.01% | 2331 |
|
2022
Q4 | $6.42M | Buy |
1,654,730
+70,474
| +4% | +$273K | ﹤0.01% | 2320 |
|
2022
Q3 | $3.85M | Sell |
1,584,256
-19,041
| -1% | -$46.3K | ﹤0.01% | 2645 |
|
2022
Q2 | $3.17M | Buy |
1,603,297
+1,239,043
| +340% | +$2.45M | ﹤0.01% | 2806 |
|
2022
Q1 | $667K | Sell |
364,254
-1,156
| -0.3% | -$2.12K | ﹤0.01% | 3621 |
|
2021
Q4 | $516K | Buy |
365,410
+85,000
| +30% | +$120K | ﹤0.01% | 3804 |
|
2021
Q3 | $317K | Sell |
280,410
-15,745
| -5% | -$17.8K | ﹤0.01% | 3950 |
|
2021
Q2 | $474K | Sell |
296,155
-496,831
| -63% | -$795K | ﹤0.01% | 3730 |
|
2021
Q1 | $1.4M | Sell |
792,986
-57,188
| -7% | -$101K | ﹤0.01% | 3441 |
|
2020
Q4 | $1.66M | Buy |
850,174
+15,351
| +2% | +$30K | ﹤0.01% | 3277 |
|
2020
Q3 | $2M | Sell |
834,823
-7,672
| -0.9% | -$18.3K | ﹤0.01% | 3061 |
|
2020
Q2 | $2.47M | Sell |
842,495
-12,518
| -1% | -$36.7K | ﹤0.01% | 2928 |
|
2020
Q1 | $2.46M | Buy |
855,013
+206,429
| +32% | +$595K | ﹤0.01% | 2735 |
|
2019
Q4 | $2.59M | Buy |
648,584
+12,383
| +2% | +$49.5K | ﹤0.01% | 2964 |
|
2019
Q3 | $2.83M | Buy |
636,201
+336,953
| +113% | +$1.5M | ﹤0.01% | 2890 |
|
2019
Q2 | $1.16M | Buy |
299,248
+37,677
| +14% | +$146K | ﹤0.01% | 3310 |
|
2019
Q1 | $991K | Buy |
261,571
+26,066
| +11% | +$98.8K | ﹤0.01% | 3359 |
|
2018
Q4 | $563K | Sell |
235,505
-504
| -0.2% | -$1.21K | ﹤0.01% | 3527 |
|
2018
Q3 | $1.47M | Buy |
236,009
+26,696
| +13% | +$166K | ﹤0.01% | 3357 |
|
2018
Q2 | $944K | Buy |
209,313
+180,170
| +618% | +$813K | ﹤0.01% | 3465 |
|
2018
Q1 | $134K | Sell |
29,143
-2,262
| -7% | -$10.4K | ﹤0.01% | 3905 |
|
2017
Q4 | $101K | Buy |
31,405
+20,850
| +198% | +$67.1K | ﹤0.01% | 3969 |
|
2017
Q3 | $33K | Hold |
10,555
| – | – | ﹤0.01% | 4105 |
|
2017
Q2 | $39K | Hold |
10,555
| – | – | ﹤0.01% | 4113 |
|
2017
Q1 | $52K | Buy |
+10,555
| New | +$52K | ﹤0.01% | 4051 |
|